2007 Ann Schreiber Grant Recipient – Kuang-Hung-Cheung
Kuang-Hung Cheng, PhD
Brigham and Women’s Hospital
Animal Model to Study Ovarian Cancer Stem Cells
The high rate of therapeutic failure and tumor relapse currently seen in ovarian cancer could result from ineffective targeting of ovarian cancer stem cells. Ovarian cancer stem cells are a population of self-generating cells that are believed to be resistant to chemotherapy. Dr. Cheng is using a mouse model his laboratory developed, called the K-ras+/Pten(-) ovarian cancer model, that mirrors the disease process, precursor lesions and clinical behavior of the human disease with great accuracy. Using this model, he is hoping to isolate ovarian cancer stem cells to understand their role in resistance to drugs and tumor relapse. He also plans to test whether Mullerian Inhibiting Substance and platinum will destroy ovarian cancer stem cells in these mouse models.
Dr. Kuang-Hung Cheng is now an Assistant Professor at the Institute of Biomedical Sciences at National Sun Yat-sen University in Taiwan. His research areas of interest include cancer biology, and cancer stem cells.
The five-year survival rate for ovarian cancer has increased by only 8% in the last 30 years.
We are at a critical crossroads for supporting research into unlocking the mysteries of ovarian cancer. You can make a difference by supporting the research of the Ovarian Cancer Research Fund.
Help us find a cure for ovarian cancer. Donate online and make a difference.